IPG Photonics Expands Medical Footprint
IPG Photonics has signed an agreement to acquire 100% of Lumibird Medical. The deal is expected to close in the fourth quarter of 2026, marking a significant expansion of the company's footprint in the medical technology sector.[1][2]
The purchase price is €300 million on a cash-free, debt-free basis, which IPG Photonics plans to fund using cash on hand. The agreement also includes a contingent earn-out of up to €50 million, which is tied to performance metrics in 2026 and 2027. To protect the investment, IPG Photonics secured a warranty and indemnity insurance policy, while the seller agreed to non-solicitation and non-competition terms for three years after closing.[3][4][5][6][7]
Before the acquisition can close, it must clear regulatory hurdles in France. The deal requires authorization from the French Minister of the Economy, alongside an AMF waiver regarding a mandatory buyout offer.[8]
Key takeaways
- Contingent earn-out consideration of up to €50 million is tied to 2026 and 2027 performance. 1 source
- Closing is subject to French foreign direct investment approval and an AMF waiver regarding a mandatory buyout offer. 1 source
- The seller is subject to three-year non-solicitation and non-competition covenants post-closing. 1 source
What’s unresolved
- Final regulatory approval from French Minister of the Economy
- Granting of AMF waiver for mandatory buyout offer
Citations
- [1] IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for €300 million IPG Photonics entered into a share purchase agreement to acquire 100% of Lumibird Medical. Manifest ID 1788900056985736399 - IPG Photonics SEC Filings - interrogate via MCP
- [2] IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for €300 million The acquisition is expected to close in the fourth quarter of 2026. Manifest ID 1788900056985736399 - IPG Photonics SEC Filings - interrogate via MCP
- [3] IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for €300 million The purchase price for Lumibird Medical is €300 million on a cash-free, debt-free basis. Manifest ID 1788900056985736399 - IPG Photonics SEC Filings - interrogate via MCP
- [4] IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for €300 million IPG Photonics expects to fund the acquisition through cash on hand. Manifest ID 1788900056985736399 - IPG Photonics SEC Filings - interrogate via MCP
- [5] IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for €300 million The SPA includes a contingent earn-out of up to €50 million based on 2026 and 2027 performance metrics. Manifest ID 1788900056985736399 - IPG Photonics SEC Filings - interrogate via MCP
- [6] IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for €300 million IPG Photonics secured a warranty and indemnity insurance policy for the acquisition. Manifest ID 1788900056985736399 - IPG Photonics SEC Filings - interrogate via MCP
- [7] IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for €300 million The seller is subject to non-solicitation and non-competition undertakings for three years following the closing. Manifest ID 1788900056985736399 - IPG Photonics SEC Filings - interrogate via MCP
- [8] IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for €300 million Closing is subject to authorization by the French Minister of the Economy and an AMF waiver. Manifest ID 1788900056985736399 - IPG Photonics SEC Filings - interrogate via MCP